0001365916-22-000072.txt : 20220701 0001365916-22-000072.hdr.sgml : 20220701 20220701164543 ACCESSION NUMBER: 0001365916-22-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220701 DATE AS OF CHANGE: 20220701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELSEY NICOLE CENTRAL INDEX KEY: 0001714653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 221062061 MAIL ADDRESS: STREET 1: AMYRIS, INC. STREET 2: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4 1 wf-form4_165670832552138.xml FORM 4 X0306 4 2022-06-30 0 0001365916 AMYRIS, INC. AMRS 0001714653 KELSEY NICOLE C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 0 1 0 0 CHIEF LEGAL OFFICER- SECRETARY Common Stock 2022-06-30 4 S 0 94033 1.8017 D 63333 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as part of personal liquidity planning for tax purposes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.765 to $1.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. /s/ Nicole Kelsey 2022-07-01